Insulin pump manufacturer scaling compliance and digital operations
Sequel Med Tech is a clinical-stage medical device company building insulin pumps, launched in 2023 and already at 201–500 employees. The tech stack reveals a heavily regulated, compliance-first operation: Salesforce + NetSuite for core systems, Snowflake + Databricks + dbt for data, and Webflow/WordPress for patient-facing content. Active hiring is skewed 70% senior/staff/director roles, with sales and engineering leading velocity — a pattern typical of device companies scaling post-launch while managing FDA and HIPAA constraints. Projects span product launches, CRM hardening, and patient digital training, mirroring pain points around compliance automation and organizational scaling.
Notable leadership hires: Learning & Development Director
Sequel Med Tech develops insulin pumps and related diabetes-care solutions for people with insulin-dependent diabetes. The company was founded in 2023 and is based in Manchester, NH. Operations span product development (insulin pump design and launch), sales and commercial infrastructure (NetSuite and Salesforce foundation), and clinical/regulatory compliance (HIPAA and FDA). The organization is actively hiring across sales, engineering, healthcare, and operations, with emphasis on senior practitioners — reflecting the resource intensity of medical device manufacturing, regulatory approval, and market entry.
Salesforce, NetSuite, Snowflake, Databricks, AWS, dbt, Airbyte, and Lightdash for core systems; WordPress, Webflow, and Drupal for patient-facing sites; Microsoft 365, SharePoint, and Teams for internal ops.
Launching a new insulin pump, building HIPAA-compliant CRM infrastructure, integrating third-party systems with NetSuite, automating documentation, and rolling out phased digital training for patients and internal sales reps.
Other companies in the same industry, closest in size